Final results of a self-apposing paclitaxel-eluting stent fOr the PErcutaNeous treatment of de novo lesions in native bifurcated coronary arteries study

EuroIntervention 2016;12:356-358 published online ahead of print June 2015. DOI: 10.4244/EIJY15M06_02

Christoph Naber
Christoph K. Naber1*, MD; Stylianos A. Pyxaras1, MD; Holger Nef2, MD, PhD; Alexander J. IJsselmuiden3, MD, PhD; Carlo Briguori4, MD, PhD; Christian Schlundt5, MD; Joanna Wykrzykowska6, MD, PhD; Franz R. Eberli7, MD, PhD; Helge Möllmann8, MD, PhD; Søren Galatius9, MD, DMSci; Johannes Rieber10, MD; Philippe Commeau11, MD; Robert-Jan van Geuns12, MD, PhD; David Bouchez1. Contilia Heart and Vascular Center, Elisabeth-Krankenhaus, Essen, Germany; 2. Universitätsklinikum Giessen, Giessen, Germany; 3. Albert Schweitzer Ziekenhuis, Dordrecht, The Netherlands; 4. Clinica Mediterranea Hospital, Naples, Italy; 5. Universitätsk

Aims: We aimed to evaluate the long-term safety and efficacy of the STENTYS self-apposing paclitaxel-eluting stent (STENTYS-PES) in bifurcation lesions in routine clinical practice.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

bifurcationcoronary diseasedisconnectable stentclinical researchkissing balloon inflationself-apposition
Coronary interventionsStents and scaffoldsBifurcation lesionsTools, devices and techniquesTools, devices and techniques
Read next article
Very high-pressure dilatation for undilatable coronary lesions: indications and results with a new dedicated balloon

Latest news